Finance

Lists
Why is 002940 down 3,90%?
Dive Deeper
002940:SHE
Zhejiang Anglikang Pharmaceutical Co Ltd
CN¥21,21
-3,90%
(-0,86) 1D
14 Okt., 15:04:21 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002940...
Open
CN¥21,99
High
CN¥22,00
Low
CN¥20,90
Mkt. cap
4,45 mjd
Avg. vol.
9,07 m
Volume
6,41 m
Dividend
1,18%
Quarterly dividend
CN¥0,06
Ex-dividend date
22 Jun. 2026
P/E ratio
37,93
52-wk high
CN¥48,90
52-wk low
CN¥20,90
EPS
CN¥0,56
Shares outstanding
201,73 m
No. of employees
1 k
Open
CN¥21,99
High
CN¥22,00
Low
CN¥20,90
Mkt. cap
4,45 mjd
Avg. vol.
9,07 m
Volume
6,41 m
Dividend
1,18%
Quarterly dividend
CN¥0,06
Ex-dividend date
22 Jun. 2026
P/E ratio
37,93
52-wk high
CN¥48,90
52-wk low
CN¥20,90
EPS
CN¥0,56
Shares outstanding
201,73 m
No. of employees
1 k
News stories
From web sources and news partners
About Zhejiang Anglikang Pharmaceutical Co Ltd
CEO-
Employees1,24 k
Founded30 Des. 2001
Headquarters-
SectorPharmaceutical industry
Websitealkpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
330,81 m
369,64 m
340,16 m
286,88 m
Cost of goods sold
202,07 m
221,21 m
215,60 m
165,79 m
Cost of revenue
202,07 m
221,21 m
215,60 m
165,79 m
Research and development expenses
37,79 m
22,18 m
34,11 m
30,89 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63,63 m
65,01 m
61,98 m
54,48 m
Operating expense
104,52 m
92,72 m
94,14 m
87,23 m
Total operating expenses
306,59 m
313,93 m
309,73 m
253,02 m
Operating income
24,22 m
55,71 m
30,42 m
33,86 m
Other non operating income
-1,04 m
692,58 k
-2,27 m
1,65 m
EBT including unusual items
17,80 m
67,76 m
24,18 m
48,96 m
EBT excluding unusual items
21,92 m
56,31 m
27,92 m
31,74 m
Income tax expense
396,68 k
11,54 m
792,30 k
5,46 m
Effective tax rate
2,23%
17,03%
3,28%
11,16%
Other operating expenses
3,62 m
3,29 m
-95,92 k
3,10 m
Net income
11,76 m
47,75 m
17,65 m
37,27 m
Net profit margin
3,56%
12,92%
5,19%
12,99%
Earnings per share
-
-
-
-
Interest and investment income
3,40 m
2,60 m
2,78 m
2,20 m
Interest expense
-3,28 m
-3,01 m
-3,00 m
-2,78 m
Net interest expenses
120,15 k
-403,65 k
-224,39 k
-575,41 k
Depreciation and amortization charges
-
-
-
-
EBITDA
45,95 m
74,90 m
49,61 m
52,67 m
Gain or loss from assets sale
-53,31 k
27,78 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme